Berlin, Germany, June 21, 2024 – Today Bayer AG, together with Charité – Universitätsmedizin Berlin, presented plans for the construction of the Berlin Center for Gene and Cell Therapies. The project is being substantially financed and supported by Germany’s Federal Government as well as the State of Berlin. The aim of the joint project is to bring these groundbreaking technologies to patients more quickly while creating a leading biotech ecosystem for innovative therapies in Berlin.
The potential for cell and gene therapies (CGTs) is considered to be enormous….
